Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 0 | 0 | 87 | 62 | 0 |
| Gross Profit | N/A | N/A | 87 | 62 | N/A |
| Operating Expenses | 4,247 | 8,472 | 5,327 | 4,415 | 1,140 |
| Operating Income | -4,247 | -8,472 | -5,240 | -4,354 | -1,140 |
| Interest Expense | 102 | 586 | 903 | 117 | 56 |
| Other Income | 58 | -172 | 180 | 1,763 | -5 |
| Pre-tax Income | -4,292 | -9,230 | -5,962 | -2,708 | -1,202 |
| Net Income Continuous | -4,292 | -9,230 | -5,962 | -2,708 | -1,202 |
| Net Income | $-4,292 | $-9,230 | $-5,962 | $-2,708 | $-1,202 |
| EPS Basic Total Ops | -17.70 | -49.50 | -50.50 | -225.81 | -32.26 |
| EPS Basic Continuous Ops | -17.75 | -49.51 | -50.40 | -45.31 | -26.91 |
| EPS Diluted Total Ops | -17.70 | -49.50 | -50.50 | -225.81 | -32.26 |
| EPS Diluted Continuous Ops | -17.75 | -49.51 | -50.40 | -45.31 | -26.91 |
| EBITDA(a) | $-4,242 | $-8,239 | $-4,443 | $-4,290 | $-1,140 |